Joseph Kim

Joseph Kim, MD, is a Professor and Chief of the Division of Surgical Oncology at his institution, with additional affiliations at the Markey Cancer Center and Translational Oncology Research Program. He holds the Patrick F. Hagihara, M.D. Professorship/Chair in General Surgery.

• Education: Doctor of Medicine from Loyola University Stritch School of Medicine (1998), Residency at University of Cincinnati (2003), Bachelor of Arts from Northwestern University (1993)

His research focuses on surgical oncology with specific emphasis on:

• Pancreatic and liver cancer
• Germline testing protocols
• Immunotherapy combinations
• Molecular mechanisms in colorectal cancer
• Intraarterial chemotherapy delivery
• Hereditary cancer predisposition

Recent work examines:

• HRAS transcript levels in colorectal cancer prognosis
• CCR9-targeting monoclonal antibodies for pancreatic cancer
• Germline testing implementation
• Hepatic artery infusion for rural cancer treatment
• Pathogenic variant reporting systems

Current projects include:

• MORPHEUS-LIVER immunotherapy umbrella trial (Genentech)
• Autogene cevumeran + atezolizumab trial in pancreatic cancer (Genentech)
• Cabozantinib + pembrolizumab trials in metastatic pancreatic cancer (Exelixis)
• PREVENT hernia prevention trial with Phasix Mesh (Becton Dickinson)